CoChat

Effects of Recombinant Human Growth Hormone in Patients With Severe Sepsis

Open access
VOERMAN, HUBERTUS J., STRACK VAN SCHIJNDEL, ROBERT J. M., JOHAN GROENEVELD, A. B., BOER, HANS DE, NAUTA, JOS P., VAN DER VEEN, EDUARD A., THUS, LAMBERTUS G. · 1992 · Annals of Surgery
Cited by 149

The DOI matches its Crossref record.

Abstract

The objective of this study was to evaluate the safety and the effect of recombinant exogenous growth hormone (GH) on nitrogen production in patients with severe sepsis. It was designed as a prospective, randomized, placebo-controlled trial, and performed in the medical intensive care unit of a university hospital. Twenty patients admitted with septic shock and receiving standard parenteral nutrition served as subjects. Treatment consisted of GH 0.1 mg/kg/day or placebo administered as continuous intravenous infusion on the second, third, and fourth days after admission. The study period was eight days. During GH administration, nitrogen production decreased significantly in the GH group and increased in controls (p < 0.01). Nitrogen balance became slightly positive in the GH group during treatment: 1.2 +/- 6.4 versus controls -3.7 +/- 3.8 g/day (day 3) (p < 0.05). Within 24 hours after cessation of treatment, differences between GH and controls disappeared. 3-Methylhistidine excretion as a measure of absolute muscle breakdown declined during the study period, but did not differ between groups. The levels of insulin, insulinlike growth factor 1, glycerol, free fatty acids, and beta-hydroxybutyrate increased during treatment. Despite continuous intravenous administration, GH levels gradually declined during the 3 treatment days, indicating increased metabolic clearance. Side effects other than insulin resistance were not observed. Growth hormone administration reduces nitrogen production and improves nitrogen balance in patients with severe sepsis. These effects are not sustained after cessation of treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000658-199212000-00006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 149

Metadata

Authors
VOERMAN, H. J., STRACK VAN SCHIJNDEL, R. J. M., JOHAN GROENEVELD, A. B., BOER, H. D., NAUTA, J. P., VAN DER VEEN, E. A., & THUS, L. G.
Venue
Annals of Surgery
Published
1992-12
Volume
216
Issue
6
Pages
648-655
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2073154101
Cited by
149
References
0
FWCI
4.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Recombinant Human Growth Hormone in Patients With Severe Sepsis. https://app.cochat.ai/papers/10.1097/00000658-199212000-00006
The paper
VOERMAN, H. J., STRACK VAN SCHIJNDEL, R. J. M., JOHAN GROENEVELD, A. B., BOER, H. D., NAUTA, J. P., VAN DER VEEN, E. A., & THUS, L. G. (1992). Effects of Recombinant Human Growth Hormone in Patients With Severe Sepsis. Annals of Surgery. https://doi.org/10.1097/00000658-199212000-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.